On June 1, 2021 Voisin Consulting Life Sciences (VCLS), a leading global HealthTech product development consultancy company, reported the acquisition of Quanta Medical, a privately-held company focusing on designing, implementing and reporting clinical studies with proprietary digital tools for the healthcare industry (Press release, VCLS, JUN 1, 2021, View Source [SID1234583324]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The transaction brings together two high-quality, innovative, and growing organizations with similar cultures and a shared commitment on high quality and efficient clinical trial protocol design and execution, from Phase 1 to post-approval studies.
The combination will address the growing market need for de-centralised and hybrid trial solutions with increasing volume of patient data from multiple data sources.
Biopharma, medical device and cosmetic manufacturers of all sizes will benefit from broader service offerings, deeper therapeutic expertise, digital healthcare technology innovation, and functional talent and capabilities.
"This acquisition will reinforce VCLS with a broaden foothold in the clinical operations space. Quanta Medical’s experience in protocol design and in running interventional and non-interventional clinical studies with a patient-centric approach, complements our clinical operations capacity. Quanta Medical’s expertise in Health Risk Assessment will also be a tremendous addition to VCLS. QData, its Malagasy subsidiary specializing in data management and biostatistics, also offers a suite of robust e-clinical applications. Both participate greatly to VCLS end-to-end solutions for HealthTech developers. We look forward to adding the talented employees of Quanta Medical and QData to our organization," said Emmanuelle Voisin, Founder and CEO of VCLS.
"I am thrilled to be joining with VCLS, a company with similar culture and values. I’m deeply indebted to Quanta Medical and QData outstanding employees who have helped me over the years bring healthcare to patients in a smart and efficient way", said Othar Zourabichvili, Founder & CEO of Quanta Medical and QData. "I am confident that VCLS, as a global leader in regulatory science and clinical operations, is the best organization to carry this expertise forward."
Redoaks (Benoît David) acted as the Sole Financial Advisor to both parties. Redoaks assisted Quanta Medical and Voisin Consulting Life Sciences in preparing and coordinating the process, organising the due diligence, providing sector and process intelligence, and helping in the negotiation of the transaction key terms.